E66
Conditions
Interventions
Group 1: The observation group consists of adults with obesity undergoing bariatric surgery during the study period and taking at least one medication (excl. postbariatric medication) after discharge.
Sponsors
Universität Leipzig
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Bariatric surgery during the study period - Written informed consent to participate in the study - Sufficient language skills to participate in the study - Intake of at least on peroral drug (excl. postbariatric drugs such as proton pump inhibitors, ursodeoxycholic acid and postbariatric supplements) - Discharge to home
Exclusion criteria
Exclusion criteria: - Non-fulfillment of inclusion criteria - Rejection of participation by the patient or the treating physician of the study centre - Discontinuation of all peroral medications after discharge
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Type and number of potential and manifest drug-related problems detected three weeks after surgery. Drug-related problems will be identified via medication analysis and patient and physician interviews. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Type and number of differences between discharge medication and patient- and physician-reported medication. - Type and number of medication changes made by physicians after surgery (reported by the primary care physician). - Number of medications prescribed that are consistent with the advice and recommendations for pharmacotherapy after bariatric surgery that can be found in the literature. - Type, number, and success of solutions proposed by pharmacists and physicians involved in the project for the detected drug-related problems. | — |
Countries
Germany
Contacts
Public ContactThilo Bertsche
ZAMS - Zentrum für Arzneimittelsicherheit, Universität und Universitätsklinikum Leipzig; Klinische Pharmazie, Institut für Pharmazie, Medizinische Fakultät, Universität Leipzig
Outcome results
None listed